Your browser doesn't support javascript.
loading
A case report of clozapine-treatment-resistant schizophrenia successfully managed with brexpiprazole combination therapy.
Orsolini, Laura; Bellagamba, Silvia; Salvi, Virginio; Volpe, Umberto.
Afiliação
  • Orsolini L; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy. Electronic address: l.orsolini@staff.univpm.it.
  • Bellagamba S; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy.
  • Salvi V; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy.
  • Volpe U; Unit of Clinical Psychiatry, Department of Neurosciences/DIMSC, School of Medicine and Surgery, Polytechnic University of Marche, Ancona, Italy.
Asian J Psychiatr ; 72: 103121, 2022 Jun.
Article em En | MEDLINE | ID: mdl-35427934
Clozapine-resistant schizophrenia (CRS) occurs in 40%- 70% of clozapine-treated schizophrenic patients. Hereby we describe a 20-year-old CRS subject with comorbid cannabinoid use disorder, successfully treated with clozapine-brexpiprazole combination, subsequently switched to clozapine plus long-acting injectable aripiprazole.
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Esquizofrenia / Antipsicóticos / Clozapina Limite: Adult / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article